News
COVID-19 variants may prompt additional Moderna vaccine
January 26, 2021
Moderna said lab tests have shown its COVID-19 vaccine could protect against the U.K. strain but that it is less effective against the strain identified in South Africa.
News
Even patients with cancer in remission at risk for severe COVID-19
January 26, 2021
Cancer patients, regardless of their age, and even if they are in remission, should be prioritized for vaccination against COVID-19.
News
More than one-third of COVID-19 infections are asymptomatic: Review
January 26, 2021
“To reduce transmission from people who are presymptomatic or asymptomatic, we need to shift our testing focus to at-home screening.”
News
Vaccines may not be as effective against variants
January 25, 2021
To slow the spread of the new strains, Dr. Fauci said, people should get vaccinated as soon as possible.
News
ColCORONA: Colchicine reduces complications in outpatient COVID-19
January 25, 2021
The use of colchicine was reported to significantly reduce hospitalizations, the need for mechanical ventilation, and deaths.
News
Full-dose anticoagulation reduces need for life support in COVID-19
January 25, 2021
“We have treatments that are improving outcomes but not as many that reduce mortality, so we’re hopeful when the full dataset comes in that will be confirmed.”
![1]()
News
Income inequality plus race drive COVID incidence, death rates in U.S.
January 25, 2021
Researchers mined data from the CDC, the Census Bureau, the Kaiser Family Foundation, and other sources for 3,142 U.S. counties.
Article
What we know and don’t know about virus variants and vaccines
January 22, 2021
One of the major concerns remains the ability of COVID-19 vaccines to work on new strains.
News
Controversy flares over ivermectin for COVID-19
January 22, 2021
Critics have said there are not enough data to institute a protocol.
![1]()
News
Monoclonal antibody combo treatment reduces viral load in mild to moderate COVID-19
January 22, 2021
Bamlanivimab alone in three different single-infusion doses showed no significant reduction in viral load, compared with placebo.
